Answers are grounded in this paper and cite their sources.
Introduction Post‐ERCP pancreatitis (PEP) remains the most frequent complication of endoscopic retrograde cholangiopancreatography (ERCP). Earlier syntheses pooled trials with different fluids in each arm, so the contribution of volume could not be separated from that of fluid composition. Methods PubMed, Web of Science, and Scopus were searched from inception to June 15, 2026 (PROSPERO CRD420261453240). We included randomized controlled trials (RCTs) of aggressive versus standard periprocedural hydration in adults undergoing first‐time ERCP, using lactated Ringer's solution (LRS) in both arms. Risk ratios (RR) and mean differences (MD) were pooled with random‐effects models; bias was assessed with Cochrane RoB 2 and certainty of evidence with Grading of Recommendations Assessment, Development and Evaluation (GRADE). Results Nine RCTs (2060 patients) were included. Aggressive hydration reduced overall PEP from 13.6% to 5.2% (RR 0.39; 95% CI 0.27–0.56; low certainty). Moderate‐to‐severe PEP (RR 0.37; 95% CI 0.17–0.82), hyperamylasemia (RR 0.61; 95% CI 0.48–0.79), and abdominal pain (RR 0.46; 95% CI 0.26–0.82) were also reduced, all with low or very low certainty; the pooled difference in hospital stay (MD − 0.77 days; 95% CI −1.40 to −0.15; I 2 = 92.7%) was uninterpretable owing to extreme heterogeneity. Fluid overload was too infrequent to be informative (6 events). The overall PEP estimate was robust to excluding high risk of bias and 2026 trials but attenuated when restricted to the three low‐risk‐of‐bias trials (RR 0.52; 95% CI 0.26–1.03). Conclusions Aggressive periprocedural LRS may reduce overall PEP when rectal NSAIDs are not used (low certainty). Any added benefit in patients already receiving rectal NSAIDs remains unproven.
No takes yet. Share an insight, caveat, or question.
Al-Harbi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: